Related Experiment Video
Updated: Aug 11, 2026
04:47
A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
Quantifying influenza vaccine efficacy and antigenic distance
Vishal Gupta1, David J Earl, Michael W Deem
1Departments of Bioengineering and Physics & Astronomy, Rice University, 6100 Main Street-MS 142, Houston, TX 77005-1892, USA.
Vaccine
|February 8, 2006
Summary
A new antigenic distance measure accurately predicts influenza vaccine efficacy. This method improves upon current phylogenetic and ferret assays for designing and monitoring seasonal flu vaccines.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Annual influenza vaccines are crucial for public health.
- Assessing vaccine effectiveness relies on predicting strain compatibility.
- Current methods for measuring antigenic distance have limitations.
Purpose of the Study:
- To introduce a novel antigenic distance measure for influenza A viruses.
- To evaluate the correlation of this new measure with vaccine efficacy.
- To compare the new measure against existing methods.
Main Methods:
- Developed a new antigenic distance metric between vaccine and circulating influenza A strains.
- Correlated this measure with historical H3N2 vaccine efficacies (1971-2004).
- Compared performance against phylogenetic analyses and ferret antisera inhibition assays.
Main Results:
- The new antigenic distance measure showed a strong correlation with H3N2 vaccine efficacy.
- This correlation surpassed that of current state-of-the-art phylogenetic and ferret assays.
- A theoretical model of immune response to influenza vaccination also correlated with efficacy.
Conclusions:
- The novel antigenic distance measure is a reliable predictor of influenza vaccine efficacy.
- This metric offers improved performance over existing methods for vaccine strain selection.
- Recommended for use in designing annual influenza vaccines and monitoring efficacy.
